The Global Digital Pathology Market in terms of revenue was estimated to be worth $736 million in 2021 and is poised to reach $1,371 million by 2026, growing at a CAGR of 13.2% from 2022 to 2026. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The growth in this market is mainly driven by factors such as the increasing adoption of digital pathology to enhance lab efficiency, the rising incidence of cancer, and the growing applications of digital pathology in drug development and companion diagnostics. Moreover, the introduction of affordable scanners for private pathology practices has opened greater opportunities for market growth.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=844
Browse in-depth TOC on "Digital Pathology Market”
279 – Tables
43 – Figures
268 – Pages
Key Player
The major players in the global Digital Pathology market include Leica Biosystems (US), Koninklijke Philips N.V. (Netherlands), and Hamamatsu Photonics (Japan)were the top players in the Digital Pathology market during the forecast period. Other major players in the market include Sectra AB (Sweden), F. Hoffmann-La Roche Ltd. (Switzerland), Visiopharm A/S (Denmark), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN (US), Huron Digital Pathology (Canada), Corista (US), Indica Labs (US), OptraSCAN (India), Glencoe Software (US), Inspirata (US), Mikroscan Technologies (US), and Kanteron Systems (Spain).
Drivers: Increasing adoption of digital pathology to enhance lab efficiency
The increasing adoption of digital pathology is driving the global digital pathology market. Digital pathology is used in diagnosis and treatment of diseases. It has the potential to revolutionize the diagnosis of diseases by providing accurate, efficient, and cost-effective solutions. Digital pathology solutions are used to store, manage, and analyze digital images of tissue and organ slides. This helps in quick diagnosis and reduces turnaround time. Moreover, digital pathology solutions can be linked to electronic medical records, which helps in seamless sharing of information between healthcare providers. This, in turn, helps in improving clinical outcomes and patient care. The increasing demand for enhanced lab efficiency is also driving the growth of the global digital pathology market.
Opportunities: Introduction of affordable scanners for private pathology practices
The introduction of affordable scanners for private pathology practices presents an opportunity for the digital pathology market. With the ability to scan slides at a lower cost, private practices are able to benefit from the advantages of digital pathology, such as increased accuracy and efficiency, while avoiding the high costs associated with traditional hardware and software. Additionally, these affordable scanners can help bridge the gap between larger pathology labs and smaller private practices, allowing them to access the same technology and benefit from the same advantages even with limited resources. This can help to improve diagnostic accuracy, reduce costs, and improve patient outcomes.
Enquiry Before Buying this Report:
https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=201524381
Restraint: High cost of digital pathology systems
Digital pathology systems are expensive and require significant capital investment. The cost of the hardware, software and services associated with the system can be quite high. This is a major factor that is likely to restrain the growth of the digital pathology market. The cost of a digital pathology system can range from USD 50,000 to several million dollars depending on the features and capabilities of the system. This is a major factor that is likely to restrain the growth of the digital pathology market.
Challenge: Shortage of trained pathologists
The current shortage of trained pathologists poses a challenge to the digital pathology market. This is because digital pathology requires skilled professionals to interpret the digital images of tissue samples which are created using digital imaging and image analysis technologies. The lack of trained professionals raises concerns about the accuracy of digital pathology results and the quality of care provided. Additionally, it also limits the ability of digital pathology to be utilized in clinical settings. To address this challenge, initiatives such as training programs and collaborations between academic institutions and private companies are being implemented. This will help to ensure that qualified pathologists are available to interpret digital pathology images. Additionally, digital pathology platforms are also being developed to reduce the need for expertise in order for users to accurately interpret the images.
The scanners segment accounted for the largest share of the digital pathology market.
Digital pathology scanners create whole-slide images (WSI) from glass slides. Converting the images into digital form helps view, analyse, manage, share, and store them easily and efficiently. The scanner identifies certain key points on the tissue and scans it piece by piece. Scanners capture several image resolutions, compress them, and store them in an image file. Along with these benefits, the large share of the scanners segment can be attributed to the high price of scanners and the increasing adoption of digital pathology solutions.
The human pathology segment accounted for the largest share of the digital pathology market.
Human pathology is the study and diagnosis of diseases by examining organs, tissues, cells, and bodily fluids. It presents information drawn from morphologic and clinical laboratory studies with direct relevance to understanding human diseases. The human pathology segment accounted for the largest share of this market. This is due to the increasing number of cancer research activities and growing collaborations among research institutes, universities, and pathology laboratories.
The market in North America is projected to witness the highest growth rate during the forecast period (2021–2026).
North America accounted for the largest share of the digital pathology market in 2020. The increasing prevalence of cancer, rising demand for quality diagnostics, the introduction of favorable reimbursement policies, and the implementation of favorable initiatives by the governments in the US and Canada are major factors driving the growth of the digital pathology market in North America.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=844
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Research Insight:https://www.marketsandmarkets.com/ResearchInsight/digital-pathology-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/pathology.asp
Related Report:
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek